Since May 2026, PatrickToxConsulting has been collaborating with McArthur & Associates (RMcAA), a Basel‑based consulting firm, as an Associate Consultant. This partnership strengthens the service offering by integrating complementary expertise in regulatory toxicology, nonclinical strategy, and preclinical translatability.
Expertise Contributed within RMcAA
Regulatory toxicology (ICH, EMA, FDA)
Nonclinical strategy and development plan preparation
GLP study oversight and CRO interactions
Risk evaluation: impurities, residual solvents, extractables & leachable (ICH Q3A/B/C/D, M7)
Support for regulatory submissions (IB, IND, IMPD, CTD 2.4/2.6, BLA, NDA, MAA)
Scientific and regulatory due diligence
Strategic support for biotech companies preparing interactions with health authorities.
RMcAA web site : https://www.rmcaa.org/index.html